[The retinopathy of prematurity].
Throughout a four years period the development of retinopathy of prematurity (ROP) was determined amongst neonates considered 'at risk' for acquiring this condition. Fifty-six out of 249 neonates developed some degree of ROP. Comparison of the ROP-group with a group of 56 controls (admitted in the same period and matched for sex, birth-weight and gestational age) showed significant differences for sepsis, blood-transfusions and the period of O2-monitoring/period of O2-administration. The most consistent factor to which the development of ROP related was gestational age at the time of birth; no gestational age group however turned out to be absolutely devoid of ROP. This suggests that screening for ROP should not be restricted to 'high-risk' neonates only.
D001803:Blood Transfusion; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009887:Ophthalmoscopy; D010092:Oximetry / Q000379:methods; D010100:Oxygen / Q000032:analysis; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects; D012178:Retinopathy of Prematurity / Q000175:diagnosis* / Q000209:etiology
D010100:Oxygen
Prematuren-retinopathie (retinopathy of prematurity, ROP).